Daiichi Life Insurance Co. Ltd. Invests $3.21 Million in HCA Healthcare, Inc. $HCA

Daiichi Life Insurance Co. Ltd. bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 8,244 shares of the company's stock, valued at approximately $3,214,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sumitomo Life Insurance Co. grew its position in HCA Healthcare by 1.0% during the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company's stock worth $946,000 after buying an additional 20 shares in the last quarter. MJP Associates Inc. ADV increased its position in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company's stock valued at $350,000 after purchasing an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC raised its stake in shares of HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company's stock valued at $140,000 after purchasing an additional 21 shares in the last quarter. Anchyra Partners LLC increased its holdings in HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company's stock valued at $278,000 after buying an additional 21 shares during the period. Finally, Plato Investment Management Ltd lifted its holdings in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company's stock worth $1,833,000 after acquiring an additional 22 shares during the period. Institutional investors own 62.73% of the company's stock.

Analysts Set New Price Targets

Several research firms recently issued reports on HCA. JPMorgan Chase & Co. dropped their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating for the company in a research report on Thursday. Truist Financial dropped their target price on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a report on Monday, July 27th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a research report on Tuesday, July 7th. Stephens reduced their target price on shares of HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating on the stock in a research note on Monday, April 27th. Finally, KeyCorp dropped their target price on shares of HCA Healthcare from $475.00 to $435.00 and set an "overweight" rating for the company in a research report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $462.64.

HCA Healthcare Stock Performance

Shares of HCA opened at $429.08 on Monday. The stock has a fifty day moving average price of $397.16 and a two-hundred day moving average price of $443.77. The company has a market cap of $92.90 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm's quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company posted $6.84 earnings per share. As a group, research analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare's dividend payout ratio is 10.45%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source